The Centers for Medicare & Medicaid Services has announced a six-month nationwide moratorium on new Medicare enrollments for home health agencies and hospice providers, citing concerns about fraud, waste, and abuse in two sectors that serve some of the nation’s most vulnerable patients. The action, announced May 13, 2026, applies to new Medicare enrollment applications […]
Category Archives: Medicare
ATLMed News, GLP-1 Drug, Healthcare Challenges, Medicaid, Medicare
Federal Agreements Announced to Lower GLP-1 Drug Prices and Expand Coverage in 2026
14
Jan
Jan
On November 6, 2025, the Trump administration announced new pricing and coverage agreements with Eli Lilly and Novo Nordisk for widely used glucagon-like peptide-1 (GLP-1) receptor agonists, including tirzepatide (Mounjaro®, Zepbound®) and semaglutide (Ozempic®, Wegovy®). These agreements aim to lower out-of-pocket costs for some patients and expand access under federal health programs beginning in 2026. […]